2Steiner R, Stewart JF, Cantwell BM, et al. Adriamycin alone or in combination with vincristine in the treatment of advanced breast cancer[J]. Eur J Cancer, 1983,(10):1553-1557.
3Paridaens R, Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a european organization for research and treatment of cancer randomized study with cross-over[J].J Clin Oncol, 2000,(18):724-733.
4Blum JL, Jones, SE, Buzdar AU, et al. A multicenter phase Ⅱ sludy of capecitahine in paclitaxel-refractory metastatic breast cancer [J]. J Clln Oncol, 1999,(17):485-493.
5Gregory RK, Powles TJ, Chang JC, et al. A randomized trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breas [J]. Eur J Cancer, 1997, (33):2194-2197.
6Flkson G, Gehnan RS, Pandya K J, et al. Eastern cooperative ontology group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission [J]. J Clin Oncol, 1998,( 16): 1669-1676.
7uss HB, Case LD, Richards F, et al. Interrupted versus continuous chemotherapy in patients with metastatic breast cancer[J]. N Engl J Med, 1991 ,(325): 1342-1348.
1[1]Heinemann V. Gemcitabine plus cisplatin for the treatment of metastatic breast cancer[ J]. Clin Breast Cancer,2002,3 (Suppl 1 ): S24-S29.
2[2]Seidman AD. Gemcitabine as single-agent therapy in the management of advanced breast cancer [ J ]. Oncology, 2001,15(2) (Suppl 3): 11-14.
3[3]Jurga L,Misurova E, Kovac V, et al. The role of cisplatin in chemotherapy of advanced breast cancer[J]. Neoplasma, 1994,41 ( 6 ) :347-352.
4[4]Carmichael J, Walling J. Advanced breast cancer:investigational role of gemcitabine[ J]. Eur J Cancer, 1997,33( Suppl 1 ): S27-S31.
5[5]Pegram MD, Lipton A, Hayes DF, et al. Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment [ J ]. J Clin Oncol, 1998, 16(8) :2659-2671.
6[6]Ray-Coquard Ⅰ, Biron P, Bachelot T, et al. Vinorelbine and cisplatin ( CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline-and/or paclitaxelcontaining regimens[ J]. Cancer, 1998 ,82 ( 1 ): 134-140.
7[7]Vassilomanolakis M, Koumakis G, Barbounis V, et al.Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines [ J ]. Ann Oncol, 2000,11(5) :1155-1160.
8[8]Moorsel CJ, Veerman G, Bergman AM, et al. Combination chemotherapy studies with gemcitabine[ J]. Semin Oncol, 1997,2,4(2): S7-S23.
9[9]Nagourney RA, Evans SS, Makalinao AJ, et al. Gemcitabine activity in primary cultures of human caner ( Abstract 2161 )[J]. Proc Am Assoc Cancer Res, 1996,37: 318.
10[1]Blum JL,Dieras V,Lo Russo PM,et al.Multicenter,phase Ⅱ study of capecitabine in taxane-pretreated metastatic breast carcinoma.Cancer,2001,92:1759
